| Rank | Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|---|
| 201 | $338M | Healthcare | Medical Devices | United States | Nasdaq | |
| 202 | $335M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 203 | $332M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 204 | $329M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 205 | $324M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 206 | $323M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 207 | $322M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 208 | $322M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 209 | $318M | Healthcare | Medical Devices | United States | Nasdaq | |
| 210 | $315M | Healthcare | Biotechnology | United States | Nasdaq | |
| 211 | $313M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 212 | $312M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 213 | $312M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 214 | $311M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 215 | $306M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 216 | $304M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 217 | $303M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 218 | $302M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 219 | $287M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 220 | $287M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 221 | $280M | Healthcare | Medical Devices | United States | Nasdaq | |
| 222 | $280M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 223 | $279M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 224 | $277M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 225 | $271M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 226 | $269M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 227 | $266M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 228 | $264M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 229 | $263M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 230 | $262M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 231 | $260M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 232 | $259M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 233 | $256M | Healthcare | Medical Devices | United States | Nasdaq | |
| 234 | $256M | Healthcare | Medical Devices | United States | Nasdaq | |
| 235 | $256M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 236 | $254M | Healthcare | Biotechnology | United States | Nasdaq | |
| 237 | $253M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 238 | $251M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 239 | $248M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 240 | $247M | Healthcare | Biotechnology | United States | Nasdaq | |
| 241 | $247M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 242 | $246M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 243 | $246M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 244 | $244M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 245 | $240M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 246 | $240M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 247 | $239M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 248 | $237M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 249 | $236M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 250 | $235M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 251 | $235M | Healthcare | Biotechnology | United States | Nasdaq | |
| 252 | $234M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 253 | $233M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 254 | $232M | Healthcare | Medical Devices | United States | Nasdaq | |
| 255 | $232M | Healthcare | Biotechnology | United States | Nasdaq | |
| 256 | $230M | Healthcare | Biotechnology | United States | Nasdaq | |
| 257 | $229M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 258 | $228M | Healthcare | Medical Devices | United States | Nasdaq | |
| 259 | $226M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 260 | $225M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 261 | $224M | Healthcare | Biotechnology | United States | Nasdaq | |
| 262 | $224M | Healthcare | Medical Devices | United States | Nasdaq | |
| 263 | $222M | Healthcare | Medical Devices | United States | Nasdaq | |
| 264 | $222M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 265 | $221M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 266 | $220M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 267 | $220M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 268 | $219M | Healthcare | Biotechnology | United States | Nasdaq | |
| 269 | $219M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 270 | $218M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 271 | $217M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 272 | $217M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 273 | $216M | Healthcare | Medical Devices | United States | Nasdaq | |
| 274 | $216M | Healthcare | Biotechnology | United States | Nasdaq | |
| 275 | $215M | Healthcare | Biotechnology | United States | Nasdaq | |
| 276 | $215M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 277 | $211M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 278 | $211M | Healthcare | Biotechnology | United States | Nasdaq | |
| 279 | $210M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 280 | $207M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 281 | $205M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 282 | $204M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 283 | $202M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 284 | $195M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 285 | $192M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 286 | $191M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 287 | $189M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 288 | $186M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 289 | $186M | Healthcare | Medical Devices | United States | Nasdaq | |
| 290 | $183M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 291 | $182M | Healthcare | Medical Devices | United States | Nasdaq | |
| 292 | $181M | Healthcare | Biotechnology | United States | Nasdaq | |
| 293 | $180M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 294 | $177M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 295 | $175M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 296 | $175M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 297 | $173M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 298 | $173M | Healthcare | Medical Devices | United States | Nasdaq | |
| 299 | $172M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 300 | $172M | Healthcare | Pharmaceuticals | United States | Nasdaq |